Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Stephan BernhardtMichaela BayerlováMartina VetterAstrid WachterDevina MitraVolker HanfTilmann LantzschChristoph UleerSusanne PeschelJutta JohnJörg BuchmannEdith WeigertKarl-Friedrich BürrigChristoph ThomssenUlrike KorfTim BeissbarthStefan WiemannEva Johanna KantelhardtPublished in: Breast cancer research : BCR (2017)
ClinicalTrials.gov, NCT01592825 . Registered on 3 May 2012.